Research & publications by Amali Lokugamage

Dr Lokugamage has conducted research in the following fields; the use of misoprostol for labour and delivery; international women's Health; reproductive & life-course epidemiology; maternity acupuncture. She has a Master’s in epidemiology.

Publications in peer reviewed journals and books

• Salker M, Teklenburg G, Molokhia M, Lavery S, Trew G, Aojanepong T, Mardon HJ, Lokugamage AU, Rai R, Landles C, Roelen BA, Quenby S, Kuijk EW, Kavelaars A, Heijnen CJ, Regan L, Macklon NS, Brosens JJ. Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss. PLoS One. 2010 Apr 21;5(4):e10287.
• Teklenburg G, Salker M, Molokhia M, Lavery S, Trew G, Aojanepong T, Mardon HJ, Lokugamage AU, Rai R, Landles C, Roelen BA, Quenby S, Kuijk EW, Kavelaars A, Heijnen CJ, Regan L, Brosens JJ, Macklon NS. Natural selection of human embryos: decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantation. PLoS One. 2010 Apr 21;5(4):e10258.
• Theresa Freeman-Wang and Amali Lokugamage. Chapter 23. Emotional aspects of cervical neoplasia screening and management. The Cervix: Ed J.Jorden, A.Singer, M.Shafi. ISBN: 978-1-4051-3137-7. Nov 2006
• Lokugamage AU, Hotopf M, Hardy R, Mishra G, Butterworth S, Wadsworth MEJ, Kuh D. Breast Cancer in Relation to Childhood Parental Divorce and Early Adult Psychiatric Disorder in a British Birth Cohort. Psychological Medicine. 2006 May 31;:1-6.
• Francis J, Rai R, Sebire NJ, El-Gaddal S, Fernandes M, Jindal P,Lokugamage A, Regan L, and Brosens JJ. Impaired Expression of Endometrial Differentation Markers and Complement Regulatory Proteins in Patients with Recurrent Pregnancy Loss Associated with Antiphospholipid Syndrome. Molecular Human Reproduction. 2006 Jul;12(7):435-442.
• Lokugamage AU, Rodeck CH. Misoprostol and pregnancy: ever increasing indications of effective usage. Curr Opin Obstet Gynecol. 2003 Dec; 15(6): 513-8.
• Lokugamage AU. Forsyth S, Sullivan KR, El Refaey H, Rodeck CH. Dinoprostone versus misoprostol: A randomised study of nulliparous women undergoing induction of labor. Acta Obstet Gynecol Scand. 2003 Feb;82(2):133-7.
• Lokugamage AU, Forsyth S, Sullivan KR, El Refaey H, Rodeck CH. Single versus double dose regimen of intravaginal misoprostol for induction of labor. A randomised trial of multiparous patients. Acta Obstet Gynecol Scand. 2003 Feb;82(2):138-42.
• Lokugamage AU, Sullivan KR, Moodley J, Rodeck CH. Treatment of postpartum haemorrhage. Acta Obstet Gynecol Scand. 2002 Oct;81(10):994
• O’Brien P, Lokugamage AU, Guillebaud J, Rodeck CH. Letter. Use of misoprostol in the third stage of labour. Lancet 2002, Feb 23, 359 (9307): 708
• Lokugamage AU, Paine M, Bassaw-Balroop K, Sullivan KR, El Refaey H, Rodeck CH. Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus Syntocinon. Aust N Z J Obstet Gynaecol 2001 Nov;41(4):411-4
• Lokugamage AU, Sullivan KR, Niculescu I, Tigere P, Onyangunga F, El Refaey H, Moodley J, Rodeck CH. A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum haemorrhage. Acta Obstet Gynecol Scand 2001 Sep;80(9):835-9
• Varma R, Tahseen S, Lokugamage AU, Kunde D. Complications of hysterectomy. Obstet Gynecol. 2001 Sep;98(3):518-9.
• Varma R, Tahseen S, Lokugamage AU, Kunde D. Vaginal route as the norm when planning hysterectomy for benign conditions: change in practice. Obstet Gynecol. 2001 Apr;97(4):613-6.
• Lokugamage AU, Rodeck CH. Chapter 8. Effective Interventions in Pregnancy to Improve Fetal Growth. P191-206. Improving Newborn Infant Health in Developing Countries. Ed: Costello A, Manandhar D. Imperial College Press 2000.